Fenwick Two-Part Series: Staying Ahead of Regulatory Pressure in Life Sciences and Tech
We’re excited to bring you two in-person CLE sessions at Fenwick’s Seattle office. These sessions will explore key regulatory issues impacting business growth, legal strategy, and investment decisions.
Session 1: Scaling Smarter: Navigating Life Sciences Regulation & Antitrust Risk from Seed to Exit
9:00 – 10:30 AM PT
As digital health and life sciences companies scale, regulatory and antitrust complexity can quickly outpace internal resources. This session will provide practical, stage-specific guidance for mitigating risk while supporting growth.
Topics will include:
- Key compliance issues across federal and state regulations, commercialization, and privacy
- Common antitrust pitfalls in communications, hiring, and strategic partnerships
- How to prepare for increased scrutiny from Series A through IPO or acquisition
Session 2: Staying Ahead of Scrutiny: Trade, Security & Contracting Strategies for Tech Companies
11:00 AM – 12:30 PM PT
As trade controls tighten and national security enforcement ramps up, tech companies face growing risks that can derail deals or stall growth. This session offers tactical, real-world guidance to stay ahead of a shifting federal and global environment.
Topics will include:
- Export control trends, strategic product classification, and customer and partner diligence
- Managing CFIUS and FOCI exposure in financing, strategic transactions, and joint ventures
- Government procurement trends and restrictions
Breakfast and lunch will be served at their respective sessions.
CLE Credit will be available to session attendees.